Nevertheless, a previous study failed to find any significant differences in the expression levels of CCL3 mRNA in peripheral blood mononuclear cells when compared between ischemic stroke patients and a healthy control group (Kostulas et al., 1999), thus suggesting that Ccl3 exerted its chemotaxis function within the CNS after ischemia. The gene discussed is CCL3; the disease is ischemic stroke.